...
首页> 外文期刊>Rheumatology >Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
【24h】

Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.

机译:在英夫利昔单抗/甲氨蝶呤治疗的RA患者中,单独停用英夫利昔单抗后淋巴瘤消退。

获取原文
获取原文并翻译 | 示例
           

摘要

Sir, The risk of lymphoma in RA patients treated with anti-TNF agents has been debated, with some discrepancy between studies . Previous reports describing tumour regression post-anti-TNF withdrawal have involved concurrent MTX cessation or EBV infection . We describe lymphoma occurring at an unusual site, which regressed on stopping infliximab alone.A 62-year-old man diagnosed with sero-positive RA in 1984 and Crohn's disease in 1988, was initially treated with prednisolone 10mg/day. Active RA prompted multiple disease-modifying drug use, including penicillamine, SSZ, MTX and LEF, all of which failed due to inefficacy or adverse effects. Infliximab with MTX was started in 2002, resulting in a DAS reduction from 8.34 to 3.22 within a month. In June 2009, the patient noticed excessive lacri-mation from his left eye. He was found to have a swelling over the inner canthus of the eye, present for 1 month.
机译:主席先生,在抗TNF药物治疗的RA患者中淋巴瘤的风险一直存在争议,研究之间存在差异。先前描述抗TNF撤药后肿瘤消退的报道涉及并发MTX停止或EBV感染。我们描述了发生在不寻常部位的淋巴瘤,仅在停用英夫利昔单抗后才复发.1984年,一名62岁的男性被诊断患有血清阳性RA,1988年被诊断为克罗恩病,最初接受泼尼松龙10mg /天的治疗。活跃的RA促使人们使用多种可改善疾病的药物,包括青霉素,SSZ,MTX和LEF,这些药物均由于无效或不良反应而失败。英菲利昔单抗与MTX于2002年开始使用,导致DAS在一个月内从8.34降至3.22。 2009年6月,患者注意到左眼有过多流泪。发现他的眼睛内can肿胀,持续了1个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号